Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
44
RLI Quote, Financials, Valuation and Earnings
Last price:
$76.80
Seasonality move
:
2.4%
Day range:
$76.07 - $77.20
52-week range:
$68.50 - $91.15
Dividend yield:
0.78%
P/E ratio:
25.29x
P/S ratio:
4.10x
P/B ratio:
4.40x
Volume:
336.5K
Avg. volume:
363.2K
1-year change:
7.12%
Market cap:
$7.1B
Revenue:
$1.8B
EPS (TTM):
$3.04
Analysts' Opinion
-
Consensus RatingRLI has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 5 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $78.25, RLI has an estimated upside of 1.8% from its current price of $76.87.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $61.00 representing 100% downside risk from its current price of $76.87.
Fair Value
-
According to the consensus of 7 analysts, RLI has 1.8% upside to fair value with a price target of $78.25 per share.
RLI vs. S&P 500
-
Over the past 5 trading days, RLI has overperformed the S&P 500 by 2.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
RLI does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
RLI revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter RLI reported revenues of $407.7M.
Earnings Growth
-
RLI earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter RLI reported earnings per share of $0.68.
Enterprise value:
5.9B
EV / Invested capital:
3.46x
Price / LTM sales:
4.10x
EV / EBIT:
16.76x
EV / Revenue:
3.41x
PEG ratio (5yr expected):
1.59x
EV / Free cash flow:
10.04x
Price / Operating cash flow:
12.09x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.02%
Net Income Margin (TTM):
16.22%
Return On Equity:
17.61%
Return On Invested Capital:
16.57%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.8B | $1.6B | $1.7B | $444.8M | $407.7M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $6.92 | $3.63 | $3.04 | $1.39 | $0.68 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $3.3B | $3.9B | $2.2B | $2.4B | |
| Total Assets | $4B | $4.4B | $4.8B | $5.3B | $5.7B | |
| Current Liabilities | $72.3M | $83.4M | $301.3M | $128.8M | $115.9M | |
| Total Liabilities | $2.8B | $3.3B | $3.5B | $3.8B | $4.1B | |
| Total Equity | $1.2B | $1.2B | $1.3B | $1.5B | $1.6B | |
| Total Debt | $149.5M | $199.7M | $199.9M | $100M | $100M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $280.7M | $466M | $592.8M | $70.9M | $103.5M | |
| Cash From Investing | $37M | -$207.1M | -$369.2M | -$53.1M | -$103.4M | |
| Cash From Financing | -$367M | -$237.1M | -$241.1M | -$9.7M | -$12.8M | |
| Free Cash Flow | $275.4M | $460.3M | $588.1M | $69.9M | $102.5M | |
RLI
Sector
Market Cap
$7.1B
$608.2M
Price % of 52-Week High
84.34%
87%
Dividend Yield
0.78%
2.03%
Shareholder Yield
--
4.07%
1-Year Price Total Return
7.12%
10.08%
Beta (5-Year)
0.704
0.587
Dividend yield:
0.78%
Annualized payout:
$2.57
Payout ratio:
84.34%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$75.43
200-day SMA
Sell
Level
$78.19
Bollinger Bands (100)
Buy
Level
73.85 - 77.77
Chaikin Money Flow
Buy
Level
11.8M
20-day SMA
Buy
Level
$74.97
Relative Strength Index (RSI14)
Buy
Level
57.67
ADX Line
Buy
Level
19.11
Williams %R
Sell
Level
-7.4799
50-day SMA
Buy
Level
$76.08
MACD (12, 26)
Buy
Level
0.13
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
32.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5313)
Sell
CA Score
(Annual)
Level (-1.0239)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.4334)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.
Stock Forecast FAQ
In the current month, RLI has received 1 Buy ratings 5 Hold ratings, and 1 Sell ratings. The RLI average analyst price target in the past 3 months is $78.25.
-
Where Will RLI Stock Be In 1 Year?
According to analysts, the consensus estimate is that RLI share price will rise to $78.25 per share over the next 12 months.
-
What Do Analysts Say About RLI?
Analysts are divided on their view about RLI share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RLI is a Sell and believe this share price will drop from its current level to $61.00.
-
What Is RLI's Price Target?
The price target for RLI over the next 1-year time period is forecast to be $78.25 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is RLI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for RLI is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RLI?
You can purchase shares of RLI via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RLI shares.
-
What Is The RLI Share Price Today?
RLI was last trading at $76.80 per share. This represents the most recent stock quote for RLI. Yesterday, RLI closed at $76.87 per share.
-
How To Buy RLI Stock Online?
In order to purchase RLI stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
